KOMPAS.com – Despite its benefits over the risks, treatment of inflammatory disease has the potential to improve the content of the risk of stomach cancer associated with infection. Thus the French scientists revealed.
Drugs “thiopurine” or drugs “immunosupressive” that prevents the immune system normally used to treat inflammatory bowels disease, the researchers said. Unfortunately this drug can increase the risk of cancer associated with the virus.
Drugs “immunosupressive” involves actions that reduce the activity or efficacy of the immune system.